Skip to Main Content

Author Details

Poul H Sorensen
British Columbia Cancer Research Centre
1989
214
72
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36761762Human antibodies targeting ENPP1 as candidate therapeutics for cancers.Front Immunol2023
37774704Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.Cell Rep Med2023
37611092A MYCN-independent mechanism mediating secretome reprogramming and metastasis in <i>MYCN</i>-amplified neuroblastoma.Sci Adv2023
37279093A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma.Clin Cancer Res2023
36761762Human antibodies targeting ENPP1 as candidate therapeutics for cancers.Front Immunol2023
37232837Pediatric Brain Tumours: Lessons from the Immune Microenvironment.Curr Oncol2023
37611092A MYCN-independent mechanism mediating secretome reprogramming and metastasis in <i>MYCN</i>-amplified neuroblastoma.Sci Adv2023
37774704Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.Cell Rep Med2023
37279093A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma.Clin Cancer Res2023
37232837Pediatric Brain Tumours: Lessons from the Immune Microenvironment.Curr Oncol2023
34294889De novo and cell line models of human mammary cell transformation reveal an essential role for Yb-1 in multiple stages of human breast cancer.Cell Death Differ2022
36229487Optineurin links Hace1-dependent Rac ubiquitylation to integrin-mediated mechanotransduction to control bacterial invasion and cell division.Nat Commun2022
36167467Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors.J Immunother Cancer2022
35365367Transsulfuration, minor player or crucial for cysteine homeostasis in cancer.Trends Cell Biol2022
36131014Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
35672300Author Correction: The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner.Nat Commun2022
36446943Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
34294889De novo and cell line models of human mammary cell transformation reveal an essential role for Yb-1 in multiple stages of human breast cancer.Cell Death Differ2022
33908607MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress.Blood2022
34971569GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity.Cancer Cell2022
35027753Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.Nat Med2022
35139387Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells.Cell Rep2022
34702771Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study.Clin Cancer Res2022
34939643Regulation of AR mRNA translation in response to acute AR pathway inhibition.Nucleic Acids Res2022
35197518Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cells.Sci Rep2022
35672300Author Correction: The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner.Nat Commun2022
35365367Transsulfuration, minor player or crucial for cysteine homeostasis in cancer.Trends Cell Biol2022
36446943Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36131014Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36229487Optineurin links Hace1-dependent Rac ubiquitylation to integrin-mediated mechanotransduction to control bacterial invasion and cell division.Nat Commun2022
36167467Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors.J Immunother Cancer2022
33908607MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress.Blood2022
34939643Regulation of AR mRNA translation in response to acute AR pathway inhibition.Nucleic Acids Res2022
34971569GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity.Cancer Cell2022
35027753Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication.Nat Med2022
35139387Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells.Cell Rep2022
35197518Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cells.Sci Rep2022
34702771Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study.Clin Cancer Res2022
33435412Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients.Curr Oncol2021
34021002Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma.Cancer Discov2021
33691136Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery.Immunity2021
34045740Author Correction: Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma.Nat Med2021
33828989NSG Mice Facilitate <i>ex vivo</i> Characterization of Ewing Sarcoma Lung Metastasis Using the PuMA Model.Front Oncol2021
34092244α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response.Acta Neuropathol Commun2021
33603169HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner.Oncogene2021
33709547Androgen receptor (AR) antagonism triggers acute succinate-mediated adaptive responses to reactivate AR signaling.EMBO Mol Med2021
33435412Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients.Curr Oncol2021
34440851Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function.Cells2021
34778803NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity.Blood Cancer Discov2021
34604225Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment.Front Cell Dev Biol2021
  • 1 - 50 of 428

Recommended Authors

Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 38
Arnulfo Mendoza
National Cancer Institute, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 10
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 13
Ken Kikuchi
Kyoto Prefectural University of Medicine
Career Start Year 2002
Number of shared co-authors 5
Massimo Squatrito
Seve Ballesteros Foundation Brain Tumor group
Career Start Year 2002
Number of shared co-authors 7
Ga??lle Pierron
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 32
Agnieszka Bronisz
Mossakowski Medical Research Institute, Polish Academy of Sciences
Career Start Year 1999
Number of shared co-authors 0
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 78
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 19
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 5
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 11
Qing-Rong Chen
Center for Biomedical Informatics and Information Technology
Career Start Year 1996
Number of shared co-authors 22
Yi-Mi Wu
University of Michigan Medical School ann arbor
Career Start Year 1995
Number of shared co-authors 3
Paul S Mischel
Stanford University
Career Start Year 1994
Number of shared co-authors 21
Andrei Goga
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 2
Frank B Furnari
University of California San Diego
Career Start Year 1992
Number of shared co-authors 12
John Easton
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 28
Simone Hettmer
University Medical Center Freiburg, University of Freiburg
Career Start Year 1990
Number of shared co-authors 28
Glenn M Marshall
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 12
Dirk Geerts
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 1
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year 1989
Number of shared co-authors 29
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 11
Choh Yeung
Center for Cancer Research, National Cancer Institute
Career Start Year 1987
Number of shared co-authors 8
Rakesh Kumar
Rutgers New Jersey Medical School
Career Start Year 1987
Number of shared co-authors 4
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 25
Patrick Kwok-Shing Ng
The University of Texas MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 1
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year 1984
Number of shared co-authors 22
Charles Keller
Children's Cancer Therapy Development Institute
Career Start Year 1980
Number of shared co-authors 28
Chi V Dang
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 7
Alex Look
Dana-Farber Cancer Institute
Career Start Year 1975
Number of shared co-authors 21

Collaborators

Timothy J Triche
Center for Epigenetics, Van Andel Research Institute
Co-authored papers 25
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 22
Alberto Delaidelli
Co-authored papers 22
Gian Luca Negri
British Columbia Cancer Research Institute
Co-authored papers 16
Gabriel Leprivier
Institute of Neuropathology, Heinrich-Heine University Dusseldorf
Co-authored papers 15
Olivier Delattre
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Co-authored papers 13
Barak Rotblat
Ben-Gurion University of the Negev
Co-authored papers 11
Michael D Taylor
The Hospital for Sick Children
Co-authored papers 11
Martin E Gleave
University of British Columbia
Co-authored papers 11
John M Maris
Children's Hospital of Philadelphia
Co-authored papers 11
Marco A Marra
University of British Columbia
Co-authored papers 9
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 9
Elizabeth R Lawlor
Seattle Children's Research Institute
Co-authored papers 9
Vijay Ramaswamy
Hospital for Sick Children
Co-authored papers 8
Frederic G Barr
Center for Cancer Research
Co-authored papers 8
Xiaochong Wu
The Hospital for Sick Children
Co-authored papers 8
Betty Luu
University of Wollongong
Co-authored papers 7
David Malkin
Hospital for Sick Children
Co-authored papers 7
Livia Garzia
The Research Institute of the McGill University Health Centre, McGill University
Co-authored papers 7
Steven J M Jones
University of British Columbia
Co-authored papers 7
Peter B Dirks
The Hospital for Sick Children, University of Toronto
Co-authored papers 6
Richard A Moore
Co-authored papers 6
Anca Sorana Morrissy
Cumming School of Medicine, University of Calgary
Co-authored papers 6
Thomas G P Gr??newald
German Cancer Research Center
Co-authored papers 6
Robert J Wechsler-Reya
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 6
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 6
William A Weiss
University of California san francisco
Co-authored papers 6
Stefan Burdach
Technische Universitat Munchen
Co-authored papers 6
G??nther H S Richter
Children's Cancer Research Center
Co-authored papers 6
Yuzhuo Wang
University of British Columbia
Co-authored papers 6
Release 1.2